A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Clinical trial NCT07085338 · RECRUITING
Trial details
- NCT number
- NCT07085338
- Sponsor
- St. Jude Children's Research Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-10
- Primary completion
- 2028-02-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.